SCHEMBL8389114

SCHEMBL8389114

C=CCOC(=O)C(Cc1ccccc1)c1ccc2ccn(Cc3ccccc3)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 6/20 0.45
▸ SNCA P37840 4/20 0.45
▸ BACE1 P56817 2/20 0.44
▸ HTR6 P50406 1/20 0.41
▸ BRD4 O60885 3/20 0.40
▸ HDAC8 Q9BY41 4/20 0.39
▸ HDAC1 Q13547 3/20 0.39
▸ HDAC2 Q92769 3/20 0.39
▸ HDAC10 Q969S8 3/20 0.39
▸ HDAC6 Q9UBN7 3/20 0.39
▸ HDAC9 Q9UKV0 3/20 0.39
▸ HDAC3 O15379 2/20 0.39
▸ HDAC4 P56524 2/20 0.39
▸ HDAC7 Q8WUI4 2/20 0.39
▸ HDAC11 Q96DB2 2/20 0.39
▸ HDAC5 Q9UQL6 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8389135 0.83 APP (0.50) APPSNCABACE1HTR6BRD4
SCHEMBL8388013 0.78 HDAC8 (0.48) APPSNCABACE1HTR6BRD4
Methyl Alcohol SCHEMBL11778530 0.74 CHRM1 (0.58) ALDH1A1TSHRCASP1NPSR1CHRM1
SCHEMBL13845248 0.73 CHRM1 (0.47) MEN1MAPTCASP1KMT2ACHRM1
SCHEMBL8391241 0.73 BACE1 (0.49) APPSNCABACE1HTR6BRD4
SCHEMBL9055984 0.72 BACE1 (0.51) APPSNCABACE1HTR6BRD4
SCHEMBL27725509 0.71 HTR6 (0.47) APPSNCABACE1HTR6BRD4
SCHEMBL8391243 0.70 PLA2G4A (0.55) APPSNCABACE1HTR6BRD4
SCHEMBL9444922 0.69 FPR2 (0.43) MEN1MAPTMAPK1CASP1KMT2A
SCHEMBL8502456 0.69 HDAC3 (0.45) APPSNCABRD4HDAC8HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877199-A ALZHEIMER'S DISEASE; SEDATIVE SANKYO COMPANY, LIMITED (JP) 1999-03-02 — — US disclosed
CN-1166169-A Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors SANKYO CO (JP) 1997-11-26 — — CN disclosed
EP-0804416-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY LIMITED (JP) 1997-11-05 — — EP disclosed
WO-1996003377-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY, LIMITED (JP) 1996-02-08 — — WO disclosed
Send feedback